Answers are grounded in this paper and cite their sources.
BACKGROUND: The comparative effectiveness of various cognitive interventions for older adults with cognitive impairment remains unclear. OBJECTIVE: This study aims to evaluate and rank cognition-oriented therapies for individuals with mild-to-moderate cognitive impairment. METHODS: We conducted a systematic review and network meta‑analysis of RCTs from nine databases up to August 2025, using random‑effects models. We assessed transitivity, heterogeneity, and consistency (global and local), as well as publication bias; sensitivity and subgroup analyses were also performed. The certainty of evidence was rated using GRADE. RESULTS: 49 RCTs (2968 participants) included. On MMSE, CT (SMD=0.81), CCT (0.49), CST (0.26), and RT (0.32) improved vs control; CRT and VR not significant; MBCT inferior (-0.45). On MoCA, CT (0.58) and CCT (0.54) superior. No global inconsistency, but local inconsistency for VR vs CRT (P = 0.039). SUCRA: CT first (90.4%) and CCT second (87.5%) for MMSE; RT first (94.0%) for MoCA but based on only two studies with high heterogeneity. Sensitivity analysis excluding high‑risk studies substantially reordered rankings (MBCT rose to second). CONCLUSION: CT and CCT showed the most consistent cognitive benefits across outcomes. However, the evidence was of low-to-moderate certainty, and rankings were fragile and sensitive to study quality. The apparent advantage of RT in the MoCA analysis was based on very limited data and is unreliable. Individualized care is advisable, but current evidence is insufficient to inform practice guidelines. Future high-quality trials are essential.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: